GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhejiang Ausun Pharmaceutical Co Ltd (SHSE:603229) » Definitions » 6-1 Month Momentum %

Zhejiang Ausun Pharmaceutical Co (SHSE:603229) 6-1 Month Momentum % : 10.90% (As of Dec. 14, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Ausun Pharmaceutical Co 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-12-14), Zhejiang Ausun Pharmaceutical Co's 6-1 Month Momentum % is 10.90%.

The industry rank for Zhejiang Ausun Pharmaceutical Co's 6-1 Month Momentum % or its related term are showing as below:

SHSE:603229's 6-1 Month Momentum % is ranked better than
71.62% of 1473 companies
in the Biotechnology industry
Industry Median: -9.53 vs SHSE:603229: 10.90

Competitive Comparison of Zhejiang Ausun Pharmaceutical Co's 6-1 Month Momentum %

For the Biotechnology subindustry, Zhejiang Ausun Pharmaceutical Co's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Ausun Pharmaceutical Co's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhejiang Ausun Pharmaceutical Co's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Zhejiang Ausun Pharmaceutical Co's 6-1 Month Momentum % falls into.



Zhejiang Ausun Pharmaceutical Co  (SHSE:603229) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Ausun Pharmaceutical Co  (SHSE:603229) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Zhejiang Ausun Pharmaceutical Co 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Zhejiang Ausun Pharmaceutical Co's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Ausun Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No.5, Donghai 4th Avenue, chemical raw materials base Linhai Park East, Zhejiang Province, Taizhou, CHN, 317016
Zhejiang Ausun Pharmaceutical Co Ltd is mainly engaged in the research and development, production and sales of specialty APIs and pharmaceutical intermediates, as well as providing customized production and research for customers. Its products portfolio includes Prostaglandins and their intermediates, Raw material medicine, Fluorine series and Develop products.
Executives
Zheng Zhi Guo Directors, senior managers
Zhang Hua Dong Directors, senior managers
Liu Bing Director

Zhejiang Ausun Pharmaceutical Co Headlines

No Headlines